Contact
Please use this form to send email to PR contact of this press release:
Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma
TO:
Please use this form to send email to PR contact of this press release:
Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma
TO: